UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000041186 |
|---|---|
| Receipt number | R000047028 |
| Scientific Title | Survey of Coronavirus disease 2019(COVID-19) |
| Date of disclosure of the study information | 2020/07/23 |
| Last modified on | 2020/07/22 02:22:54 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Survey of Coronavirus disease 2019(COVID-19)
Acronym
Survey of Coronavirus disease 2019(COVID-19)
Scientific Title
Survey of Coronavirus disease 2019(COVID-19)
Scientific Title:Acronym
Survey of Coronavirus disease 2019(COVID-19)
Region
| Japan |
Condition
Condition
COVID-19
Classification by specialty
| Medicine in general | Pneumology | Infectious disease |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To conduct a fact-finding survey of COVID-19 (including suspected cases) by accumulating clinical information.
Basic objectives2
Others
Basic objectives -Others
To identify the risk factors of death from COVID-19.
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Investigation of clinical characteristics of COVID-19 (e.g.clarification of risk factors for progression of COVID-19).
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Individuals with COVID-19 (including suspected patients)
Key exclusion criteria
Patients who did not agree participation of the study by opt out or clearly refuse its participation.
Target sample size
2000
Research contact person
Name of lead principal investigator
| 1st name | Koichi |
| Middle name | |
| Last name | Fukunaga |
Organization
Keio University School of Medicine
Division name
Division of Pulmonary Medicine, Department of Medicine
Zip code
1608582
Address
35 Shinanomachi, Shinjuku-ku, Tokyo, Japan
TEL
0333531211
kfukunaga@keio.jp
Public contact
Name of contact person
| 1st name | Makoto |
| Middle name | |
| Last name | Ishii |
Organization
Keio University School of Medicine
Division name
Division of Pulmonary Medicine,Department of Medicine
Zip code
1608582
Address
Shinanomachi 35, Shinjuku-ku, Tokyo, Japan
TEL
0333531211
Homepage URL
ishii@keio.jp
Sponsor or person
Institute
Keio University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Keio University School of Medicine
Address
35 Shinanomachi, Shinuku-ku, Tokyo, Japan
Tel
0333531211
natsuko.chiba@adst.keio.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2020 | Year | 07 | Month | 23 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2020 | Year | 05 | Month | 29 | Day |
Date of IRB
| 2020 | Year | 05 | Month | 29 | Day |
Anticipated trial start date
| 2020 | Year | 05 | Month | 29 | Day |
Last follow-up date
| 2030 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
This study is a retrospective multicenter study.
Management information
Registered date
| 2020 | Year | 07 | Month | 22 | Day |
Last modified on
| 2020 | Year | 07 | Month | 22 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047028
